A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2002
11/14/2002	US20020169215 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
11/14/2002	US20020169209 Potentiation of therapeutic effects of fatty acids
11/14/2002	US20020169203 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
11/14/2002	US20020169202 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
11/14/2002	US20020169200 Antitumor, antiinflammatory and antiarthritic agents, treating metastasis, restenosis, osteoporosis, inflammation, macular degeneration, and diabetic retinopathy
11/14/2002	US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives
11/14/2002	US20020169189 Benzamide derivatives as thrombin inhibitors
11/14/2002	US20020169186 Tetrahydroquinoline derivatives as glycine antagonists
11/14/2002	US20020169177 Imidazole and benzimidazole caspase inhibitors and uses thereof
11/14/2002	US20020169174 Xanthine phosphodiesterase V inhibitors
11/14/2002	US20020169171 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
11/14/2002	US20020169170 Arylpiperazines having activity at the serotonin 1A receptor
11/14/2002	US20020169169 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal
11/14/2002	US20020169166 Benzimidazoles that are useful in treating sexual dysfunction
11/14/2002	US20020169164 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
11/14/2002	US20020169163 1,2,3,4-tetrahydro-pyrazino(1,2-a)indole derivatives useful in treating obesity, central nerveous system diosrders, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, type II diabetes, obesity and sleep apnoea
11/14/2002	US20020169161 Bicyclic sulfanimde compounds useful for the treatment of cardiac arrhythmias
11/14/2002	US20020169160 Sulfonamide matrix metalloproteinase inhibitors
11/14/2002	US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002	US20020169150 Hormone replacement therapy
11/14/2002	US20020169144 Angiogenesis inhibition
11/14/2002	US20020169143 Methods and products related to low molecular weight heparin
11/14/2002	US20020169134 Use of substituted azetidinone compounds for the treatment of sitosterolemia
11/14/2002	US20020169133 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
11/14/2002	US20020169131 TGF-alpha polypeptides, functional fragments and methods of use therefor
11/14/2002	US20020169109 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
11/14/2002	US20020168763 Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002	US20020168434 Cyclooxygenase inhibitor; anticancer agents, Alzheimer's disease, central nervous system disorders
11/14/2002	US20020168411 Spill resistant pharmaceutical system
11/14/2002	US20020168406 Gel overcoated with polylysine
11/14/2002	US20020168358 Modulating the binding of the particular chemokines SLC (secondary lymphoid chemokine), and MIP-3b (macrophage inflammatory protein-3b), to immune system T-cells and dendritic cells to treat adverse inflammatory responses etc
11/14/2002	US20020168357 Administering to a mammal an antibody capable of binding native tissue factor, and linked covalently to a cell antigen or an effector molecule to provide complement fixing ability and antibody dependent cell mediated cytotoxicity
11/14/2002	US20020168333 Method for improving vascular access in patients with vascular shunts
11/14/2002	DE10123129A1 Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel Deuterated 3-piperidinopropiophenones and pharmaceutical compositions containing them
11/14/2002	DE10122894A1 New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases
11/14/2002	DE10121002A1 Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen Use of anthranilamides as a medicament for the treatment of arrhythmias and pharmaceutical compositions containing them
11/14/2002	DE10119680A1 Verwendung von Radikalfänger-Verbindungen zur Behandlung und Verhinderung von no-abhängigen Störungen der Mikrozirkulation Use of scavenger compounds for the treatment and prevention of no-dependent disorders of microcirculation
11/14/2002	CA2453223A1 Selective anthranilamide pyridinamides as vegfr-2 and vegfr-3 inhibitors
11/14/2002	CA2446795A1 Sulfamide, sulfamate, sulfonamide, urea, amide, alpha, alpha-difluoro amide oxalyl diamide, and heterobicycles fkbp-binding ligands
11/14/2002	CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002	CA2446396A1 N-aroyl cyclic amines
11/14/2002	CA2446365A1 Sulfonamides
11/14/2002	CA2446363A1 Potentiation of therapeutic effects of fatty acids
11/14/2002	CA2446120A1 Novel arylheteroalkylamine derivatives
11/14/2002	CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	CA2445679A1 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	CA2445504A1 Methods of treating hyperlipidemia
11/14/2002	CA2438978A1 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	CA2435142A1 Kinases and phosphatases
11/14/2002	CA2385809A1 Alkylamide compounds
11/13/2002	EP1255854A2 Interaction of nmda receptor with protein tyrosine phosphatase
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255821A2 Protein c derivatives
11/13/2002	EP1255819A2 Human kinases
11/13/2002	EP1255764A1 Purine derivatives
11/13/2002	EP1255760A1 Clavams as protease inhibitors
11/13/2002	EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/13/2002	EP1255756A1 Saccharin derivatives as orally active elastase inhibitors
11/13/2002	EP1255752A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
11/13/2002	EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002	EP1255749A1 Tyrosine derivatives with anti-leukotriene activity
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002	EP1255744A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof
11/13/2002	EP1255742A1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
11/13/2002	EP1255741A2 2- 1H]-QUINOLONE AND 2- 1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
11/13/2002	EP1255740A2 Substituted arylpyrazines
11/13/2002	EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
11/13/2002	EP1255718A1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
11/13/2002	EP1255559A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease
11/13/2002	EP1255556A2 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
11/13/2002	EP1255551A1 Use of paullone derivatives for making medicines
11/13/2002	EP1255550A2 Method for identifying and using a 2b adenosine receptor antagonists to mediate mammalian cell proliferation
11/13/2002	EP1255545A2 L-arginine in combination with other compounds for treating cardiovascular diseases
11/13/2002	EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors
11/13/2002	EP1255456A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall
11/13/2002	EP1140916B1 Heteroaryl-cyclic acetals
11/13/2002	EP1107968B1 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
11/13/2002	EP1102762B1 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
11/13/2002	EP1086092B1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
11/13/2002	EP1056451B1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
11/13/2002	EP0788795B1 Pharmacologically active 2-mercaptobenzimidazole derivatives
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379815A BAFF receptor (BCMA), immunoregulatory agent
11/13/2002	CN1379814A Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions
11/13/2002	CN1379781A Novel oligosaccharides, preparation method and pharmaceutical composition containing same
11/13/2002	CN1379777A Amino-triazolopyridine derivatives
11/13/2002	CN1379776A Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
11/13/2002	CN1379775A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/13/2002	CN1379773A Novel isoquinoline derivatives or salts thereof
11/13/2002	CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002	CN1379767A Isoxazolecarboxamide derivatives
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist

1 ... 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 ... 1595